Investigating the Role of the Post-transcriptional Gene Regulator MiR-24-3p in the Proliferation, Migration and Apoptosis of Human Arterial Smooth Muscle Cells in Arteriosclerosis Obliterans
Investigating the Role of the Post-transcriptional Gene Regulator MiR-24-3p in the Proliferation, Migration and Apoptosis of Human Arterial Smooth Muscle Cells in Arteriosclerosis Obliterans
复制标题
研究转录后基因调节因子 MiR-24-3p 在动脉硬化闭塞症中人动脉平滑肌细胞增殖、迁移和凋亡中的作用
DOI:
10.1159/000430302
复制
发表时间:
2015-07
影响因子:
--
通讯作者:
Wang, Shen-ming
中科院分区:
文献类型:
--
作者:
Wu, Wei-bin;Shi, Ya-wei;Li, Wen;Wang, Shen-ming
Aims: To explore the expression of miR-24-3p in human arteries with arteriosclerosis obliterans (ASO) as well as the role of miR-24-3p in the pathogenesis of ASO. Methods: We used quantitative real-time PCR (qRT-PCR) and in situ hybridization to monitor miR-24-3p expression in human arteries. To investigate the effect of miR-24-3p on human arterial smooth muscle cells (HASMCs), we applied cell counting and EdU assays to monitor proliferation and transwell and wound healing assays to investigate migration and flow cytometry to investigate apoptosis. Furthermore, we applied 3'-untranslated region (3'-UTR) luciferase assays to investigate the role of miR-24-3p in targeting platelet-derived growth factor receptor B (PDGFRB) and c-Myc. Results: MiR-24-3p was mainly located in the media of arteries and was downregulated in ASO arteries compared with normal arteries. Platelet-derived growth factor BB (PDGF-BB) treatment reduced the expression of miR-24-3p in primary cultured HASMCs. MiR-24-3p mimic oligos inhibited the proliferation and migration, and promotes apoptosis of HASMCs. Our 3'-UTR luciferase assays confirmed that PDGFRB and c-Myc were targets of miR-24-3p. Conclusion: The results suggest that miR-24-3p regulates the proliferation and migration of HASMCs by targeting PDGFRB and c-Myc. The PDGF/miR-24-3p/PDGFRB and PDGF/miR-24-3p/c-Myc pathways may play critical roles in the pathogenesis of ASO. These findings highlight the potential for new therapeutic targets for ASO.
登录
查看更多内容
影响因子:
5.8
作者:
Madrigal-Matute, Julio;Rotllan, Noemi;Aranda, Juan F.;Fernandez-Hernando, Carlos
通讯作者:
Fernandez-Hernando, Carlos
影响因子:
120.7
作者:
Fowkes, F. G. R.;Murray, G. D.;Butcher, I.;Heald, C. L.;Lee, R. J.;Chambless, L. E.;Folsom, A. R.;Hirsch, A. T.;Dramaix, M.;deBacker, G.;Wautrecht, J-C.;Kornitzer, M.;Newman, A. B.;Cushman, M.;Sutton-Tyrrell, K.;Lee, A. J.;Price, J. F.;d'Agostino, R. B.;Murabito, J. M.;Norman, P. E.;Jamrozik, K.;Curb, J. D.;Masaki, K. H.;Rodriquez, B. L.;Dekker, J. M.;Bouter, L. M.;Heine, R. J.;Nijpels, G.;Stehouwer, C. D. A.;Ferrucci, L.;McDermott, M. M.;Stoffers, H. E.;Hooi, J. D.;Knottnerus, J. A.;Ogren, M.;Hedblad, B.;Witteman, J. C.;Breteler, M. M. B.;Hunink, M. G. M.;Hofman, A.;Criqui, M. H.;Langer, R. D.;Fronek, A.;Hiatt, W. R.;Hamman, R.;Resnick, H. E.;Guralnik, J.;McDermott, M. M.
通讯作者:
McDermott, M. M.
DOI:
10.1161/atvbaha.114.304088
发表时间:
2014-09-01
影响因子:
8.7
作者:
Di Gregoli, Karina;Jenkins, Nicholas;Johnson, Jason L.
通讯作者:
Johnson, Jason L.
DOI:
10.3410/f.1383966.856065
发表时间:
2010-01
期刊:
--
影响因子:
--
作者:
K. Gross
通讯作者:
K. Gross
影响因子:
168.9
作者:
Lozano, Rafael;Naghavi, Mohsen;Murray, Christopher J. L.
通讯作者:
Murray, Christopher J. L.